Company / Current Assets per Share
Spyre Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$12.91
FY2025
5-year range
$1.26 / $130.65
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
#54 of 210
Health Care
What the data says
At $12.91, Spyre Therapeutics, Inc.'s current assets per share ranks #54 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $1.26 in FY2022 to $130.65 in FY2023.
Based on SEC 10-K filings.
12.91 in FY2025 with a 5-year CAGR of +20.2%.
Declined from $130.65 to $12.91 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +117.1%
- 5-Year CAGR
- +20.2%
- 10-Year CAGR
- -
Sector benchmark
#54 of 210 in Health CareTop 26% of 210This company $12.91 Sector average $170.65
▼
-92.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 23.5% year-over-year.
- Ranks #54 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.91 | -23.5% |
| FY2024 | $16.88 | -87.1% |
| FY2023 | $130.65 | +10257.5% |
| FY2022 | $1.26 | -38.8% |
| FY2021 | $2.06 | -60.0% |
| FY2020 | $5.15 | +66.9% |
| FY2019 | $3.09 | -32.9% |
| FY2018 | $4.60 | +26.5% |
| FY2017 | $3.64 | -46.4% |
| FY2016 | $6.78 | -89.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026